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24-hour urinary protein excretion was 4.6 g. The patient initially
was treated for edema with furosemide, 40 mg/day, and hydro-
chlorothiazide, 12.5 mg/day. Because the edema did not re-
spond to treatment, the furosemide dose was progressively
increased over the following two weeks to 200 mg/day; the
thiazide dose remained the same.
Because of the finding of hyponatremia, diuretics were with-
drawn after his admission to the emergency room. The patient
was treated with water restriction and oral sodium repletion;
his confusion and somnolence gradually resolved over the first
five days in hospital. He left the hospital 10 days after admission
with normal serum electrolytes and arterial blood gases.
CASE PRESENTATION
A 54-year-old man was admitted to the emergency room DISCUSSION
because he was confused and had somnolence alternating with Dr. Gerardo Gamba (Chief, Molecular Physiologyperiods of muscular rigidity. Three weeks before the admission,
Unit, Instituto Nacional de la Nutricio´n Salvador Zubira´n,progressive and generalized muscular weakness had developed.
On physical examination he was disoriented and had hyper- and Instituto de Investigationes Biome´dicas, Universidad
reflexia and spontaneous rotatory eye movements. His blood Nacional Auto´noma de Me´xico, Mexico City, Mexico):
pressure was 158/88 mm Hg. Laboratory analysis disclosed: The fine control of sodium (Na1) excretion and urine
serum glucose, 150 mg/dl; sodium, 116 mEq/liter; chloride, 81
concentration takes place in the distal nephron. As dis-mEq/liter; potassium, 2.9 mEq/liter; bicarbonate, 26.8 mmol/
cussed by Rose in a previous Forum [1], the major Na1liter; arterial pH, 7.47; and PCO2, 36.2 mm Hg. Cerebral mag-
netic resonance imaging (MRI) showed no focal lesions. transport mechanisms of the distal nephron (defined as
The patient had a history of non-insulin-dependent diabetes that portion of the nephron starting with the thick as-
mellitus for several years with progressive retinopathy and cending loop) also serve as targets for diuretic action.
nephropathy. He had been diagnosed one month before this
The patient presented here had a clinical history that isadmission with advanced nephropathy characterized by gener-
not uncommon in clinical practice. He was admitted toalized severe edema, mild chronic renal failure, and arterial
hypertension. Physical examination confirmed the presence of the emergency room with progressive muscular weak-
edema. Arterial pressure at that time was 207/105 mm Hg. ness that evolved to somnolence and a confusional state.
Laboratory analysis then revealed: serum glucose, 211 mg/dl; Magnetic resonance imaging revealed no evidence ofserum creatinine, 2.7 mg/dl; BUN, 37 mg/dl; cholesterol, 364
cerebral lesions, and his clinical status was explained bymg/dl; albumin, 3.5 g/dl; calcium, 9 mg/dl; phosphorus, 6.3
metabolic derangements such as severe hyponatremia,mg/dl; sodium, 140 mEq/liter; and potassium 4.0 mEq/liter. The
hypokalemia, and metabolic alkalosis. These metabolic
and clinical alterations resulted from inhibition of twoThe Nephrology Forum is funded in part by grants from Hoechst
major sodium transport proteins of the distal nephron.Marion Roussel, Incorporated; Amgen, Incorporated; Merck & Co.,
Incorporated; Astra Pharmaceuticals; Dialysis Clinic, Incorporated; The patient had been treated for several weeks before
and R & D Laboratories. admission to the emergency room with a combination of
two diuretic drugs: furosemide and hydrochlorothiazide.Key words: BSC1 and BSC2 genes, Bartter’s syndrome, Gitelman’s
syndrome, pseudohypoaldosteronism, Liddle’s syndrome. The first agent inhibits the function of the Na1:K1:2Cl2
cotransporter in the thick ascending limb (TAL), and 1999 by the International Society of Nephrology
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the second one inhibits the function of the Na1:Cl2 co- crynic acid, torasemide, and piretanide) [3]. Net NaCl
reabsorption in the TAL is increased by hormones gener-transporter in the distal convoluted tubule (DCT). Inhi-
bition of sodium reabsorption in two contiguous nephron ating cAMP via their respective Gs-coupled receptors,
such as vasopressin [4]. In the mouse, vasopressin modu-segments resulted in potentiation of the diuretic action.
In addition, although the patient had moderate chronic lates the NaCl transport mode. In its absence, NaCl is
transported in the TAL through a K1-independent, butrenal failure, his exaggerated response to diuretics re-
sulted in renal loss of sodium, potassium, and hydrogen. nevertheless furosemide-sensitive, Na1:Cl2 mechanism,
whereas its presence switches the NaCl transport modeSodium chloride and potassium repletion plus with-
drawal of the diuretics restored the metabolic state of to the furosemide-sensitive Na1:K1:2Cl2 cotransporter
[5]. A similar regulatory mechanism occurs in rabbitthe patient.
The general mechanism of sodium reabsorption along TAL, which exhibits a furosemide-sensitive Na1:Cl2 co-
transporter that is switched to a Na1:K1:2Cl2 mode inthe nephron is based on the following physiologic events:
The Na1:K1:ATPase polarized to the basolateral mem- the presence of hypertonicity [6]. The presence of two
furosemide-sensitive cotransport mechanisms in the TALbrane provides the electrochemical gradient that allows
sodium to be transported from the lumen to the intersti- is supported by the finding of two classes of bumetanide-
binding sites in membrane preparations from wholetial space; in the apical membrane, with the exception
of the collecting duct (CD), Na1 is cotransported or mouse kidneys [7], high-affinity sites of approximately
150 kDa and low-affinity sites of approximately 75 kDa.contra-transported with other molecules (for example,
glucose, amino acid residues) or ions (for example, Cl2, This finding suggests that Na1:Cl2 and Na1:K1:2Cl2 co-
transporters in the TAL could correspond to two differ-K1), which are carried against their gradient by a group
of proteins collectively known as secondary transporters. ent proteins. The switching of transport mode from
Na1:Cl2 to Na1:K1:2Cl2, together with the activationThe presence of each particular type of secondary trans-
porter varies along the nephron in such a way that part of the apical inwardly rectifying K1 channel (ROMK),
also regulated by vasopressin, is of crucial importanceof the characteristic heterogeneity of the nephron is ex-
plained by the amount and type of transporters ex- in the TAL function, because K1 entering the cell
through the Na1:K1:2Cl2 cotransporter is recycled to thepressed in each segment. For instance, the Na1:glucose
cotransporter is expressed only in the proximal tubule. lumen by ROMK, generating a lumen-positive potential
difference that drives the reabsorption of cations throughThus, this is the only segment of the nephron in which
glucose is reabsorbed. In the CD, and probably at the a paracellular pathway. Thus, vasopressin-induced cAMP
generation is a fundamental mechanism for regulatingend of the distal tubule [2], Na1 delivery is lower than
in the rest of the nephron, especially during sodium cation transport in the TAL because it doubles Na1
reabsorption without increasing energy output and alsodepletion; this decrease reduces the possibility for Na1
to be carried by cotransporters. In the CD, Na1 transport because it is responsible for the reabsorption of other
cations such as Ca21 and Mg21 [3]. Hence, combiningoccurs electrogenically in the apical membrane of the
principal cells through epithelial sodium-selective chan- loop diuretics with saline loading is the basis for hyper-
calcemia therapy, as inhibition of the Na1:K1:2Cl2 co-nels.
In this Forum, I will present an overview of the molec- transporter increases urinary calcium excretion and re-
duces plasma calcium concentration.ular biology of the distal nephron Na1 transport mecha-
nisms. I will focus on the Na1 pathways in the TAL, Two genes for the Na1:K1:2Cl2 cotransporter have
been identified: (1) the renal-specific BSC1/NKCC2, lo-DCT, and CD, which are known by many clinicians as
the diuretic receptors. cated on human chromosome 15, which encodes the TAL
Na1:K1:2Cl2 cotransporter (hereafter referred to as
The thick ascending loop of Henle BSC1) [8, 9] and (2) the ubiquitous BSC2/NKCC1, lo-
cated on human chromosome 5q23.3, which is expressedThe TAL reabsorbs 15% to 20% of the glomerular
filtrate, regulates divalent mineral excretion, and plays in several tissues and cell lines encoding for the basolat-
eral and non-epithelial Na1:K1:2Cl2 cotransporter (here-a key role in the production and maintenance of renal
medullary hypertonicity. This last function provides the after referred to as BSC2) [10, 11]. Functional expression
of BSC1 and BSC2 in Xenopus laevis oocytes and HEK-kidney with the ability to form urine that can be more
diluted or concentrated than plasma. This functional ca- 293 cells, respectively, induces the expected expression
of a bumetanide-sensitive 86Rb1 transport mechanismpacity is essential for the survival of land mammals, in-
cluding humans. Figure 1A shows the molecular physiol- (substituting K1) that is Na1 and Cl2 dependent [8, 10].
Both BSC1 and BSC2 share a basic structural topologyogy of sodium reabsorption in the TAL. The major
pathway for sodium reabsorption is the apical membrane with the rest of the members of the cation-chloride gene
family. They are glycoproteins of 1095 to 1212 aminoNa1:K1:2Cl2 cotransporter, the main pharmacologic tar-
get of loop diuretics (furosemide, bumetanide, etha- acid residues with molecular weights of approximately
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Fig. 1. (A) Physiology of sodium reabsorption in the thick ascending limb. (B) Predicted topology of the bumetanide-sensitive Na1:K1:2 Cl2cotrans-
porter (BSC1). Abbreviations: ATP, adenosine triphosphate; ADH, antidiuretic hormone; cAMP, cyclic AMP; PKA, protein kinase A (j); PKC,
protein kinase C (d).
165 kDa and a central hydrophobic region containing 12 forms exhibit a C-terminus of 129 residues, from which
the last 55 are not present in the longer isoforms. Inter-putative transmembrane domains flanked by amino- and
carboxy-terminal hydrophilic domains located within the estingly, the long and short C-terminal domains contain
different putative protein kinase A (PKA) and proteincell. The extracellular hydrophilic loop between putative
transmembrane domains S7 and S8 contains three N-gly- kinase C (PKC) phosphorylation sites. As Figure 2
shows, we have designated the longer and shorter iso-cosylation motifs. Several putative PKA and PKC phos-
phorylation sites are present within the amino- and car- forms as mBSC1-9 and mBSC1-4, respectively. The two
splicing events appear to be independent from each otherboxy-terminal domains (Fig. 1B).
At least six isoforms of BSC1 are expressed in the in such a way that a total of six isoforms is produced in
the mouse kidney [12].mouse kidney by the combination of two alternative
splicing mechanisms (Fig. 2) [12]. One is due to the The three mBSC1-9 isoforms cRNA (mBSC1-A9,
mBSC1-B9, and mBSC1-F9) induce expression of a bu-presence of three mutually exclusive cassette exons of
96 bp designated A, B, and F, which encode for 32 amino metanide-sensitive Na1:K1:2Cl2 cotransporter when in-
jected in Xenopus oocytes [14]. The functional signifi-acid residues corresponding to the putative second trans-
membrane domain (S2) and the contiguous intracellular cance of these isoforms is not yet understood. However,
in-situ hybridization [13] and single-nephron polymeraseloop between S2 and S3 [9, 13]. This splicing produces
three BSC1 proteins that are identical, with the exception chain reaction (PCR) studies [15] using isoform-specific
probes and primers, respectively, have shown that theof the 32 amino acids encoded by A, B, or F cassettes.
The second splicing of the BSC1 gene is the utilization mBSC1-9-type isoforms exhibit differential expression
along the TAL. The F-isoform is expressed at the innerof a poly-adenylation site in the intron between coding
exons 16 and 17, which predicts a protein with a signifi- stripe of the outer medulla, A-isoform is mainly ex-
pressed at the outer stripe of the outer medulla, andcantly shorter C-terminal domain. This splicing produces
two BSC1 proteins that are identical at the N-terminus B-isoform is exclusively localized at the cortical TAL.
This distribution suggests that A, B, and F cassettes couldand the transmembrane domains, but which differ in
the length and sequence of the C-terminal domain. The endow different affinity and/or transport capacity to
mBSC1-9 isoforms. Unfortunately, kinetic analysis of thelonger isoforms exhibit a C-terminus of 457 amino acid
residues, from which the last 383 are not present in the three isoforms is not available. In this regard, however,
experiments with human and shark basolateral isoforms,shorter isoform. In contrast, the shorter, truncated iso-
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Fig. 2. Predicted topology of the six alternatively splicing isoforms of BSC1 in mouse kidney. Domains encoded by the mutually exclusive cassette
exons B, A, and F are shown in white, black and gray, respectively. Black dots and boxes represent putative PKC and PKA sites, respectively.
BSC2, provide preliminary evidence that kinetic proper- TAL cells. The mBSC1-9-specific antibodies label the
apical membrane of all cells along the entire length ofties of extracellular Na1 and K1, as well as bumetanide
inhibition, but not extracellular Cl2 concentration, are TAL, whereas mBSC1-4 expression exhibits a heteroge-
neous pattern in which not all TAL cells are labeled. Inat least partly determined by the sequence of the first
and second membrane domains [16]. addition, cortical TAL appears to express less mBSC1-4
than do outer medullary segments. This heterogeneityThe functional properties of mBSC1-4 isoforms have
not yet been established because these isoforms do not may underlie the observed difference in vasopressin-
sensitive Na1:Cl2 cotransport in cortical TAL versusexpress Na1:K1:2Cl2 cotransport in Xenopus oocytes.
However, recent data from our laboratory show that medullary TAL [17].
Molecular probes of BSC1 and polyclonal antibodiesmBSC1-4 isoforms exert a dominant-negative function
on the ion transport expressed by full-length mBSC1-9 directed against BSC1 have been used in recent years
to determine the role of BSC1 gene expression underisoforms [14]. On one hand, Xenopus oocytes injected
with any of the three mBSC1-9 isoforms showed that several physiologic and pathophysiologic conditions. We
have shown that high or low NaCl intake, dehydration,PKA activation or inhibition with cAMP or H89, respec-
tively, does not affect the function of the Na1:K1:2Cl2 water loading, and furosemide administration do not
affect BSC1 expression at the mRNA level [18]. In con-cotransporter [14]. On the other hand, the dominant-
negative effect of mBSC1-4 is reversed by cAMP. There- trast, modifications in K1 and acid-base metabolism
seem to affect BSC1 gene expression. It has been knownfore it is highly likely that the negative effect of mBSC1-4
plays a key role in the cAMP-induced activation of the for many years that severe potassium depletion increases
urinary chloride excretion [19] at least in part due toNa1:K1:2Cl2 cotransporter. Supporting this conclusion,
Mount et al, using immunofluorescence studies, have reduction in Cl2 reabsorption in TAL and DCT [20].
In a recent study, Amlal et al observed that potassiumrecently shown that both isoforms are coexpressed in
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depletion reduced Cl2 reabsorption in the TAL and brane. This extrusion of Na1 reduces the intracellular
Na1 concentration, thereby hyperpolarizing DCT cellsdownregulated BSC1 mRNA expression [21].
The Na1:K1:2Cl2 cotransporter also is involved in and stimulating Ca21 entry at the apical membrane
through Ca21 channels [32]. This secondary effect ofrenal acid excretion because NH41 can substitute for K1
yielding a Na1:NH41:2Cl2 cotransporter. Through this thiazides on Ca21 reabsorption constitutes the basis for
their use in the treatment of calcium stone disease andmechanism, the NH41 produced in the proximal tubule
usually is reabsorbed in the TAL and recirculated into also might explain the protective effect of thiazides in
osteoporosis [33, 34].the medulla to be excreted by the collecting duct. Thus,
one of the potential responses to acidosis is increased The thiazide-sensitive Na1:Cl2 cotransporter from the
winter flounder urinary bladder was the first electroneu-reabsorption of NH41 by the TAL. This hypothesis is
supported by the fact that acidosis increases mRNA and tral Na1-coupled Cl2 cotransporter to be identified at
the molecular level following a functional expressiontransport activity of BSC1 [22]. Finally, downregulation
of BSC1 protein expression in the kidney from rats with strategy in Xenopus laevis oocytes (flTSC) [35]. Then an
RNA probe constructed from the fish cDNA was usedadriamycin-induced nephrotic syndrome [23] might ex-
plain the defect in the diluting capacity observed in the to clone, by homology, thiazide-sensitive cotransporter
(TSC) from rat kidney (rTSC) [8]. Functional expressionnephrotic syndrome.
Mutations of the human BSC1 gene (S1c12a1) [24, 25] of flTSC and rTSC in Xenopus oocytes gives rise to a
22Na1 transport uptake mechanism that is Cl2-dependentoccur in patients with classic and antenatal Bartter’s syn-
drome, a monogenic disease characterized by metabolic and inhibitable by thiazide-type diuretics, with an inhibi-
tion profile (polythiazide . metolazone . hydrochloro-alkalosis, hypokalemia, severe salt wasting, and hyper-
calciuria. Mutations range from alterations on a single thiazide . chlorothiazide) similar to that previously shown
for inhibition of Cl2-dependent Na1 absorption [36], andamino acid residue to premature termination of the co-
transporter protein. No functional studies of mutated thiazide competition for the high-affinity [3H]metolazone
binding sites on renal cortical membranes [37]. In addition,clones have been reported, however. Bartter’s syndrome
is a monogenic but heterogeneous disease; three genes Na1 and Cl2 kinetics on the expressed flTSC and rTSC
in Xenopus oocytes are identical to those observed inhave been identified in the TAL as causes of the syn-
drome: BSC1 [24, 25], the apical ATP-sensitive K1 chan- the endogenous cotransporters [35].
Thiazide-sensitive cotransporters share a similar sec-nel [26], and the basolateral Cl2 channel [27]. In addition,
some of the kindreds studied by Simon et al have no ondary structure with the other members of the Na1-
coupled Cl2 cotransporter family, as deduced from theevidence of mutations in any of these three genes [27],
so at least a fourth gene must be implicated. Kurtz dis- hydrophobicity analysis following the Kyte-Doolittle al-
gorithm [38]. Hence flTSC, rTSC, and human TSCs arecussed the clinical, physiologic, and genetic alterations
in Bartter’s syndrome in detail in a recent Forum [28]. glycoproteins of 1002 to 1028 amino acid residues with
a molecular weight of approximately 120 kDa that also
The distal convoluted tubule show the basic structure of 12 putative transmembrane
domains, flanked by two hydrophilic amino- and car-The distal convoluted tubule (DCT) reabsorbs 5%
to 7% of the glomerular filtrate. Figure 3A shows the boxy-terminal domains containing several putative PKC
and PKA phosphorylation sites (Fig. 3B). We have re-molecular physiology of Na1 reabsorption in the DCT.
The activity of the Na1:K1:ATPase in DCT is compara- cently shown by mutation analysis of rTSC that there
are two N-linked glycosylation sites in the loop betweenble to that in the TAL [29]. The major sodium reabsorp-
tion pathway in the apical membrane is the Na1:Cl2 S7 and S8 that are absolutely required for the protein
to be functional.cotransporter, which is the major target for benzothiadia-
zine-type diuretics (chlorthalidone, hydrochlorothiazide, Seven different genes of the cation-coupled Cl2 co-
transporter gene family have been cloned from verte-bendroflumethiazide, metolazone) [30]. Loop diuretics
do not inhibit this cotransporter. In addition to Na1 brate sources. A phylogenetic tree depicting the relation-
ship among the protein sequences of members in thistransport, the DCT is involved in calcium excretion and
in urine concentration just as is the TAL [31]. Sodium family is shown in Figure 4A. Two genes encode the
BSC1 and BSC2 Na1:K1:2Cl2 cotransporters [8, 10].and Ca21 reabsorption in the DCT are inversely related.
Thus, inhibition of the Na1:Cl2 cotransporter with thia- One gene encodes the thiazide-sensitive Na1:Cl2 co-
transporter (TSC1) [35], and four genes encode thezide diuretics increases Ca21 reabsorption. How thiazides
affect calcium reabsorption is still unclear, but they might K1:Cl2 cotransporters: one gene that is ubiquitously ex-
pressed (KCC1) [39], another gene that exhibits brain-be functionally linked through an indirect mechanism.
Thiazides inhibit NaCl entry at the apical membrane, specific expression (KCC2) [40], and two more genes
(KCC3 and KCC4) that are expressed in several organswhereas intracellular Na1 continuously leaves the cells
through the Na1:K1:ATPase at the basolateral mem- [41]. In addition, putative cation-coupled Cl2 cotrans-
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Fig. 3. (A) Physiology of sodium reabsorption in the distal convoluted tubule. (B) Predicted topology of the thiazide-sensitive Na1:Cl2 cotransporter
(TSC1). Abbreviations are: PKA, protein kinase A (j); PKC, protein kinase C (d).
porter cDNAs and/or expressed sequence tags (ESTs) residues contain a putative PKA phosphorylation site,
which is of potential importance in human TSC regula-have been characterized from invertebrate sources such
as Drosophila melanogaster, Manduca sexta, Caenorhab- tion. The functional significance of these isoforms is still
under investigation.ditis elegans, yeast, a cyanobacterium, and the tobacco
plant [42]. As Figure 4A shows, two branches are clearly For some time now, cRNA probes constructed by anti-
sense in-vitro translation of rTSC cDNA and antibodiesseparated. One includes all the Na1-coupled Cl2 cotrans-
porters and another includes the Na1-independent, K1- directed against an N-terminal rTSC fusion protein have
been used to localize rTSC mRNA and protein in ratcoupled Cl2 cotransporters. The degree of identity
among BSC1, BSC2, and TSC1 is over 50%. The strong- and human kidney using immunofluorescence and in-
situ hybridization analysis [45, 46]. These studies haveest homology is observed in the transmembrane domains
but is also evident in the interconnecting loops as well shown that TSC is expressed in the apical membrane of
the DCT and connecting duct (CNT). The expression ofas in the C-terminal domain. Homology between the
Na1-coupled Cl2 cotransporters and the K1-coupled Cl2 TSC starts abruptly at the beginning of the DCT; no
label is observed in the thick ascending limb. The TSCcotransporters is approximately 20% (Fig. 4B).
As with BSC1 and BSC2 genes, the molecular diversity signal can be detected along the DCT, in the DCT-
CNT transition zone, and also at the early part of theof the TSC gene is increased by the existence of alterna-
tively spliced isoforms. Northern blot analyses have connecting tubule. As with physiologic studies [31], im-
munolocalization analysis with TSC antibodies dividesshown that flTSC transcript in the flounder urinary blad-
der is approximately 3.7 kb, whereas in other tissues the DCT into an “early” segment, in which TSC protein
is heavily expressed, and a “late” segment, in which TSC(brain, eye, ovary, intestine, muscle, heart) it is approxi-
mately 3.0 kb [35]. This truncated isoform is also present label is progressively reduced, in part because of an in-
creasing number of intercalated cells that are not stained.in several tissues of various species of marine and fresh-
water teleosts (Merino A, Gamba G, unpublished data). Ultrastructural localization of rTSC protein with immu-
nogold labeling revealed its presence in the DCT apicalThiazide-sensitive cotransporters also exhibit isoforms
that probably are due to splicing at the C-terminal do- membrane and also in subapical vesicles [45].
Hypertrophy of the DCT has been implicated in neph-main. Alignment analysis between human and rat TSCs
shows that the human protein contains 17 amino acids ron adaptation during chronic changes in NaCl and water
metabolism, as well as after long-term furosemide ad-that are not present in rTSCs. The finding that this addi-
tional segment is encoded in a separate exon suggests ministration. Morphologic and functional changes in the
DCT, such as an increase in Na1:K1:ATPase activity atthe presence of two alternatively spliced isoforms at the
C-terminal domain [43, 44]. The extra 17 amino acid the basolateral membrane surface area, and in the num-
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one study shows increased levels using in-situ hybridiza-
tion techniques [53], whereas another shows no change
using RT-PCR-base quantitation of rTSC [18].
It has been recognized for many years that estrogens
increase renal sodium reabsorption, but their mechanism
of action remains largely unknown [54]. One possibility
that could at least partly explain the renal effect of estro-
gens is the recent finding that estradiol regulates expres-
sion of rTSC protein in the kidney. The response to a
single injection of the diuretic bendroflumethiazide is
greater in female than in male rats, a difference that
disappears six weeks after oophorectomy [55]. Work by
Verlander et al supports this finding [56]. They observed
by Western blot analysis of renal proteins that oophorec-
tomy in rats decreases rTSC1 immunoreactivity and re-
duces the density of immunogold rTSC label in DCT. In
addition, estradiol restores DCT morphology and rTSC
labels to normal. The mechanism of estrogen-induced
expression of rTSC is still unknown, but it is likely to
be indirect, because expression of estrogen receptors has
not been found in DCT epithelial cells [57]. In addition,
we have not observed a difference in rTSC mRNA levels
in renal total RNA obtained from male and female rats,
with or without gonadectomy [Meade P, Gamba G, un-
published data].
More than 80 different mutations along the human
TSC gene (S1c12a3) have been found in patients with
Gitelman’s syndrome [43, 58, 59], an autosomal-recessive
monogenic disease characterized by hypokalemic alkalo-
sis in conjunction with hypocalciuria and hypomagnese-
mia [60]. Because all patients up until now have had
mutations in the TSC gene, it is likely that no other
genes are involved in Gitelman’s syndrome. Given theFig. 4. (A) Phylogenetic tree of the cation-chloride coupled cotrans-
recessive inheritance of Gitelman’s syndrome, it is inter-porter gene family. (B) Diagram showing percentage of homology
among members of the cation-chloride gene family. esting that most patients are “compound heterozygous.”
This consideration raises interesting possibilities for hid-
den phenotypes in the heterozygous subjects, such as
moderately low blood pressure, predisposition for di-ber and size of mitochondria in the DCT have been
uretic-induced hypokalemia, and protection against os-proposed as the pathophysiologic mechanism behind the
teoporosis. Kurtz reviewed this interesting disease in adiuretic resistance syndrome [for excellent reviews see
recent Forum [28].Refs. 47 and 48]. Microperfusion studies have shown
that Na1 reabsorption and K1 secretion by the DCT is
The collecting ductincreased in this adapted state [49, 50] and that increased
The CD, the main target of aldosterone action, reab-expression and/or function of rTSC could be involved,
sorbs 1% to 2% of the glomerular filtrate. This nephronas [3H]metolazone binding sites in membrane extracts
segment controls the final Na1 excretion [61]. Figure 5Afrom renal cortex also increase [51]. In support of this
shows the mechanism for sodium reabsorption in thehypothesis, Loon et al found a reduced response to furo-
CD. In the basolateral membrane, the function of thesemide after one month of therapy despite well-main-
Na1:K1:ATPase provides the electrochemical gradienttained GFR in humans [52]. During prolonged furosemide
for vectorial Na1 transport and, as in many other high-administration, these patients exhibited an increased re-
resistance epithelia such as colon and frog skin, the majorsponse to chlorothiazide, so Loon et al proposed that
sodium transport mechanism in the apical membrane isthese patients developed an increase in the capacity of
an epithelial Na1 channel that is highly selective for Na1Na1 reabsorption in the DCT because of treatment with
over other cations. This Na1 channel is the target for thefurosemide. The effect of chronic furosemide administra-
tion on rTSC mRNA expression is not clear; however, K1-sparing diuretics such as amiloride and triamterene.
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Thus, the major sodium transport pathway in the CD is Caenorhabditis elegans, collectively called degenerins,
which are involved in mechanotransduction and neuro-also a diuretic receptor.
Two independent groups, following a functional ex- degeneration [71]. (3) Brain-specific peptide or proton-
gated ion channels identified from the snail Helix aspersapression strategy in Xenopus laevis oocytes, achieved the
molecular identification of the amiloride-sensitive Na1 central nervous system (FMRF) [72] and human brain
that are involved in acid sensing. In addition, Darbouxchannel in the rat. The cDNA of the a subunit was the
first one to be identified and named as ENaC (epithelial et al have recently identified a gonad-specific, amiloride-
sensitive cation channel from Drosophila melanogasterNa1 channel) [62, 63]. However, the level of amiloride-
sensitive Na1 current that was obtained in Xenopus oo- [73]; this channel is implicated in gametogenesis and
early embryonic development.cytes after expression of the rat a-ENaC cDNA was
much lower than that after expression of the total mRNA All members of the ENaC superfamily share a similar
secondary structure, a linear representation of which isof the rat colon. This finding suggested that the full
expression of the channel was not achieved because shown in Fig. 5B. They are polypeptides of 550 to 700
amino acid residues with molecular weights between 60another subunit(s) or cofactor(s) was missing. Then
Canessa et al, also using Xenopus oocytes as an expres- and 80 kDa. The ENaC is organized as a heteromulti-
meric channel composed of one b, one g, and two asion system, employed a functional complementation
strategy to successfully identify two homologous sub- subunits [74]. Hydrophobicity analysis of each subunit
revealed the presence of two membrane spanning do-units: b-ENaC and g-ENaC [64]. Coexpression of the
three subunits in Xenopus oocytes reconstitutes a chan- mains (M1 and M2) flanked by short amino- and carboxy-
terminal hydrophilic domains located within the cell. Anel with ion selectivity, gating properties, and pharmaco-
logic profile identical to those of the native channel. large extracellular hydrophilic domain connects M1 and
M2, and this domain constitutes about two-thirds of theAfter cloning ENaC cDNA from rat colon mRNA, the
three cDNA subunits were identified from other tissues, protein. The extracellular loop is highly glycosylated,
increasing the protein molecular weight, and possessessuch as kidney and lung, and from other species such as
human, cattle, chicken, and Xenopus [65, 66]. In addition, several cysteine residues that are conserved in all mem-
bers of the family. These properties suggest that disulfidecomparison of the ENaC subunits sequence with geno-
mic databases revealed homology with some ESTs. This bridges among isoforms play an important role in the
tertiary structure of the protein. In this regard, Vallet etcybernetic cloning approach allowed Waldman and col-
leagues to identify a novel subunit of ENaC from a hu- al following a functional complementation strategy in
Xenopus oocytes, recently cloned an endogenous prote-man kidney cDNA library that is also expressed in brain,
pancreas, testis, and ovary [67]. This novel subunit is 40% ase, CAP1, which increases the activity of the channel
when secreted to the extracellular space [75]. The highestidentical to a-ENaC and was named d-ENaC. Similar to
a-ENaC, when expressed alone d-ENaC can induce a degree of homology among members of the ENaC family
is found at the membrane-spanning domains, in particu-small amiloride-sensitive Na1 current that is increased
several times when coexpressed together with b-ENaC lar within the M2 domain, in which several amino acid
residues determine cation specificity and amiloride sensi-and g-ENaC. The reconstituted channel, however, pos-
sesses biophysical and pharmacologic properties that are tivity [65, 76]. The N- and C-terminal hydrophilic do-
mains are critical for the regulation of ENaC functionslightly different from the channel obtained with a, b,
and g ENaC subunits. Thus d-ENaC is similar, but not and activity.
With combined techniques such as in-situ hybridiza-identical, to a-ENaC. The human a-ENaC gene maps
to chromosome 12p13 [68]; b-ENaC and g-ENaC genes tion and immunocytochemistry using probes and anti-
bodies, respectively, against each ENaC subunit, thehave been co-localized in chromosome 16p12-13 [69];
and d-ENaC gene maps to chromosome 1p36.3-36.6 [70]. Na1-channel proteins have been localized to epithelia
involved in sodium reabsorption, such as those fromThe ENaC was the first member of a superfamily of ion
channels to be cloned. This family includes membrane kidney, colon, urinary bladder, sweat glands, and lung.
In addition, expression of ENaC has been detected inproteins that are associated with a wide range of physio-
logic functions. As Figure 6A shows, in the phylogenetic nonepithelial cells such as lymphocytes [77], osteoblasts
[78], and epidermis [79]. In the kidney, as expected fromtree of this family, three branches are clearly identified:
(1) Channels involved in vectorial Na1 transport in epi- previous physiologic data [80], ENaC subunits are ex-
pressed in the apical membrane of principal cells fromthelia represented by a, b, g, and d subunits. The a-ENaC
and d-ENaC are the most closely related subunits, the late distal tubule, the cortical collecting duct, and
the outer and inner medullary collecting ducts [81].whereas b-ENaC and g-ENaC are at a similar distance
from a. Figure 6B depicts the percentage of homology Sodium reabsorption in the CD is regulated by several
hormones, among which aldosterone and vasopressinamong ENaC subunits. (2) Amiloride-sensitive proteins,
such as DEG-1, MEC-4, and MEC-10 from the nematode are the most imporant (Fig. 5A). Physiologic studies
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Fig. 5. (A) Physiology of sodium reabsorp-
tion in the principal cells of the collecting duct.
(B) Linear representation of the epithelial
Na1 channel (ENaC) a, b and g subunits.
Black boxes represent the predicted mem-
brane spanning domains and gray boxes the
cystine-rich segment of the extracellular loop.
demonstrated that a low-sodium diet, a state associated or in single amino acid changes. Functional expression
of PHA-1-type mutated cRNA in Xenopus oocyteswith high aldosterone levels, is characterized by a 100-
fold increase in amiloride-sensitive whole-cell current in shows that the mutations produce a significant reduction
in the channel function [87]. Hummler et al developedthe CD [82]. Patch clamp analysis revealed an increase
in the number of active channels in the membrane with- animal models of ENaC mutations that are helping to
increase our understanding of the physiologic role ofout any change in the open probability [83]; after several
days of Na1 depletion, there likely is an increase in the ENaC in several tissues [88]. An a-ENaC knockout
mouse does not reproduce human PHA-1; all mice diednumber of channels at the apical membrane of the CD.
However, the three ENaC subunits are constitutively within a few hours after birth because of pulmonary
edema [88], a complication not present in the humanexpressed in the CD, and chronic stimulation with aldo-
sterone has little effect on a-ENaC mRNA levels and disease. However, a-ENaC knockout mice were geneti-
cally rescued by transgenic expression of a-ENaC. Ani-no effect on b-ENaC and g-ENaC [84, 85]. Thus Renard
and colleagues have postulated that the effect of aldoste- mals with this new phenotype have no problems with
lung liquid clearance, and approximately 50% died dur-rone in the CD is an increase in sodium reabsorption
by activation of previously existent channels, probably ing the first two weeks because of severe PHA-1 with
metabolic acidosis and dehydration. The other 50%because of a redistribution of preformed proteins to the
apical membrane [85]. As in other nephron segments, reached adult life with a compensated PHA-1, featuring
a severalfold increase in plasma aldosterone levels [89].vasopressin acts in the CD by increasing intracellular
cAMP levels; this increase in turn induces insertion of Liddle’s syndrome is an autosomal-dominant disease
characterized by early onset of arterial hypertension withchannels into the apical plasma membrane. The effect
of vasopressin through phosphorylation of ENaC is con- hypokalemia and metabolic alkalosis, but with low
plasma renin and aldosterone concentrations [90]. Be-sistent with the presence of several putative PKA sites
within the carboxy-terminal domain in b and g subunits cause of its resemblance to primary aldosteronism, the
syndrome also is known as pseudohyperaldosteronism.and also with the recent finding that PKA and PKC stimu-
lation increase phosphorylation of these subunits [86]. Liddle’s syndrome is resistant to mineralocorticoids, re-
sponds to amiloride, and disappears after successful renalEpithelial Na1 channel mutations produce two heredi-
tary syndromes characterized by disruption of the salt transplantation. Botero-Velez et al therefore suggested
that the primary defect could be located in the renal CDreabsorption and volume homeostasis: severe volume
depletion (pseudohypoaldosteronism type 1, PHA-1), [91]. Shimkets and colleagues demonstrated that Liddle’s
syndrome is due to b-ENaC or g-ENaC mutations thatand arterial hypertension (Liddle’s syndrome). The for-
mer is an autosomal-recessive disease present in infants result in truncation or single amino acid changes in the
carboxy-terminus after the second membrane domainwho develop, shortly after birth, severe salt wasting with
dehydration, hyponatremia, hyperkalemia, and meta- [92]. Thus Liddle’s syndrome is also a monogenic but
heterogenic disease, as it can be produced by mutationbolic acidosis, all of which are resistant to mineralocorti-
coid hormones. This metabolic picture suggests a defect of two different genes. The mutations in Liddle’s syn-
drome are “gain-of-function” mutations, because theyin sodium reabsorption in the CD. Indeed, loss-of-func-
tion mutations in a-ENaC, b-ENaC, or g-ENaC have all produce ENaCs, which exhibit increased amiloride-
sensitive Na1 currents [93, 94], due to both an increasebeen demonstrated in these patients, making PHA-1 a
monogenic, but nevertheless heterogeneous disease. De- in the number of channels that reach the membrane and
an increased current per channel [95]. Deletion or mis-tected mutations result in premature protein termination
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Fig. 6. (A) Phylogenetic tree of the super-
family of amiloride-sensitive cation channels.
(B) Diagram showing percentage of homology
among the four known subunits of the epithe-
lial Na1 channels (ENaC).
sense mutations in Liddle’s syndrome always result in lenberger et al observed that mutations decrease the
channel sensitivity to intracellular Na1, which under nor-loss of a particular motif in the carboxy-terminal domain
known as PY motif (PPxY) [94, 96]. Staub and cowork- mal conditions downregulates ENaC function [100].
The genetic abnormality in Liddle’s syndrome proveders, following two-hybrid yeast system strategy, found
that this proline-rich segment is absolutely required for for the first time in humans that primary defects in renal
Na1 absorption, present since birth, produce arterial hy-binding of the channel with a protein known as Nedd4
[97]. The ENaC-Nedd4 interaction results in ubiquitina- pertension in adult life. This finding strongly supports
the Guytonian view of the mechanism of hypertensiontion of a and g subunits [98]. Ubiquitination is a biochem-
ical process that usually tags cellular proteins for rapid in which a shift of the pressure-natriuresis relationship
to the right is a necessary condition to sustain chronicdegradation. Thus the absence of a PY motif prevents
ENaC interaction with Nedd4 and ubiquitination of hypertension [101]. It also supports the observation
made by many groups that “hypertension follows theENaC, and results in channels that exhibit longer half-
life in the cellular membrane [98]. Also, Nedd4 protein kidney” in cross-renal transplantation experiments be-
tween normal and genetically hypertensive rats [102-in the nephron is heavily expressed along the CD [99].
The mechanisms by which Liddle’s mutations increase 104]. This experience also has been observed for kidney
recipients in human transplantation [105, 106].current per channel are less well understood, but Kel-
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Concluding remarks system different from that which would result from the
parallel operation of the two antiporters.The cloning of the cDNAs that encode for the major
Dr. Jaime Herrera-Acosta (Chief, Department of Ne-Na1 transporters located at the apical membrane of the
phrology, Instituto Nacional de Cardiologı´a Ignacio Cha´-TAL, DCT, and CD not only revealed the primary se-
vez, Mexico City, Mexico): Patients who develop resis-quence of these proteins, but also provided investigators
tance to loop diuretics commonly become very sensitivewith priceless tools that have been used successfully in
to thiazides. This phenomenon suggests that there is anthe last decade to generate new information about these
upregulation of TSC. Can you comment on this matter?Na1 transport pathways. The rapidly expanding knowl-
Dr. Gamba: Several studies have shown that increasededge about these transporters extends from basic analy-
sodium intake or chronic furosemide administration re-ses of structure-function relationship of the proteins to
sults in DCT hypertrophy with an increase in the sodiumtheir physiologic role in the kidney and other organs, as
transport capacity of this segment of the nephron. Chenwell as their primary role in genetic syndromes affecting
et al have shown that furosemide administration for fivesodium conservation, acid-base metabolism, and blood
days increased the amount of [3H]metolazone bindingpressure. Some of the old questions generated by clinical
to a membrane preparation from renal cortex, and sug-and physiologic research as well as by clinical observa-
gested that furosemide treatment upregulates TSC ex-tions have been answered and a lot of new questions have
pression [51]. At the mRNA levels, however, the litera-arisen, promising that exciting times for renal physiology
ture contains two contradictory studies. On one hand,will continue with the beginning of the new millennium.
Bachmann et al showed by in-situ hybridization that
seven days of furosemide treatment increased TSC
QUESTIONS AND ANSWERS mRNA expression in DCT [53]. On the other hand,
Moreno et al, using semiquantitative PCR, observed noDr. John T. Harrington (Dean, Tufts University
School of Medicine, Boston, Massachusetts): Has the change in TSC mRNA levels [18]. In this latter study,
however, the authors observed that dehydration resultedgene for the furosemide-sensitive Na1:Cl2 cotransporter
in TAL been identified? If not, what is your speculation in upregulation of TSC. Because rats treated with furose-
mide in the studies from Chen et al and Bachmann etabout it? If so, what are the structural similarities be-
tween the furosemide-sensitive Na1:Cl2 cotransporter al lost about 20% of body weight in a seven-day period,
it is possible that these rats were dehydrated. Thus, thein the TAL and the thiazide-sensitive Na1:Cl2 cotrans-
porter just downstream in the DCT? increase in TSC expression might have been related to
the dehydration syndrome rather than to the furosemideDr. Gamba: A gene coding for the furosemide-sensi-
tive Na1:Cl2 cotransporter in the TAL has not yet been treatment. No studies have been performed in which
TSC were studied at the protein level after furosemideidentified. Thus, no information is available on similari-
ties between the thiazide-sensitive and furosemide-sensi- administration. In addition, loop diuretics have no effect
on BSC expression, either at the mRNA [19] or at thetive Na1:Cl2 cotransporters. Interestingly, this last co-
transporter exhibits ion transport properties similar to protein levels [107].
Dr. Sharma Kumar (Assistant Professor of Medicine,TSC, but with diuretic sensitivity similar to BSC. Thus,
I think that the furosemide-sensitive Na1:Cl2 cotrans- Thomas Jefferson University, Philadelphia, Pennsylva-
nia): I was struck by the fact that loss-of-function muta-porter gene might be an alternatively splicing isoform
of either TSC or BSC genes, or, on the other hand, a tions of the amiloride-sensitive sodium channel lead to
severe Na1 wasting, whereas mutation of the Na1-K1-new, unidentified gene of the family could encode it.
Dr. Nicolaos E. Madias (Chief, Division of Nephrol- 2Cl2 cotransporter leads to a lesser degree of natriuresis.
This finding contrasts with the potent natriuretic effectsogy, New England Medical Center, Boston): Is the
K1-independent Na1:Cl2 transport system in the TAL of loop diuretics and the weak natriuretic effects of ami-
loride. Could you comment on these contrasting observa-a Na1:Cl2 cotransporter or a parallel Na1:H1 and
Cl2:HCO32 antiport system? tions?
Dr. Gamba: This is a very interesting issue. One possi-Dr. Gamba: Work from at least two laboratories has
shown in mouse [5] and in rabbit [6] that the furosemide bility is that the differences in the severity among these
syndromes is due to the region in which the Na1 reab-Na1:Cl2 transport system, which is clearly K1-indepen-
dent, is furosemide sensitive and is inhibited by hyperto- sorption defect occurs. The mutated cotransporters in
Bartter’s or Gitelman’s syndrome are localized to thenicity. These two conditions, the inhibition by furose-
mide and the inhibition of the transport activity in apical membrane of the TAL and DCT, respectively,
while ENaC mutations affect sodium reabsorption in thehypertonicity, are not expected for the Na1 or Cl2 up-
take due to the simultaneous operation of Na1:H1 and collecting duct. After sodium escapes reabsorption in
TAL or DCT, there is still a sodium reabsorption seg-Cl2:HCO32 antiport systems. Thus, I think that the furo-
semide-sensitive Na1:Cl2 cotransporter is a transport ment ahead. Thus, part of the Na1 can still be reab-
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sorbed, whereas when Na1 escapes reabsorption in the known that mutations in a short amino acid segment just
collecting duct, there is no more nephron ahead. Another before the second transmembrane domain of the three
possible explanation could be the degree of loss of func- ENaC subunits (abg) decrease the channel’s affinity for
tion induced by mutations on each protein. It is known the diuretic amiloride [76].
that PHA-1-type mutations completely block the ENaC Dr. Madias: Do the two isoforms of the Na1:K1:2Cl2
function. However, no studies have been reported on cotransporter exhibit different bumetanide sensitivities?
the functional consequences of BSC or TSC mutation, Do the doses of furosemide that we use in our patients
so we do not know to what extent the function of BSC affect the function of BSC outside the kidney?
or TSC cotransporter is lost with these mutations. Dr. Gamba: The answer to the first question is yes. The
Dr. Jose´-Carlos Pen˜a (Hospital Mocel, Mexico City, existence of at least two isoforms of the Na1:K1:2Cl2
Mexico): As you mentioned earlier, it is known that cotransporter was suspected several years ago because
increased NaCl intake is associated with an increase in of the difference on bumetanide kinetics of different
the sodium reabsorptive capacity of the distal nephron. tissues. The K1/2 of bumetanide affinity of BSC1 is ap-
Is the effect of sodium chloride intake on BSC and TSC proximately 0.005 mM (and in BSC2 is approximately
expression in the nephron known? 5.00 mM). The doses we use clinically usually affect only
Dr. Gamba: A chronic modification in NaCl intake the function of BSC1.
seems to affect BSC and TSC expression at the protein, Dr. Ricardo Correa-Rotter (Chief, Department of
rather than at the mRNA, level. We have shown by using Nephrology, Instituto Nacional de la Nutricio´n Salvador
Northern blot and semiquantitative PCR analysis that Zubira´n, Mexico City): You have discussed the clinical
increasing (up to 10 times) or decreasing salt intake for picture of TSC and BSC homozygous mutations, yet
a period of seven days in rats has no effect on BSC and heterozygous alterations are certainly present in some
TSC mRNA levels [18]. In contrast, at the protein level, patients. These individuals could have some degree of
Ecelbarger et al [107] and Kim et al [108], using Western tubular Na1 reabsorption dysfunction. Could you com-
blot with antibodies against BSC or TSC, respectively, ment on this possibility, and what could be expected in
have shown that high salt intake increased BSC and functional terms as well as the clinical picture?
low salt intake increased TSC protein levels. Thus, it is Dr. Gamba: Because both Bartter’s and Gitelman’s
possible that high or low salt intake increases the amount syndromes are recessive diseases, kindreds do have
of BSC or TSC cotransporters at the protein levels by members with heterozygous mutations. This is particu-
post-transcriptional modifications. larly true for Gitelman’s syndrome, as most of the pa-
Dr. Madias: Could you summarize what is known tients are compound heterozygous; that is, their muta-
about the mechanism of inhibition of the Na1:K1:2Cl2
tions for each allele of the TSC gene are different. I
cotransporter in the TAL by loop diuretics, the Na1:Cl2
expect that the clinical picture for patients with heterozy-cotransporter in the DCT by thiazide diuretics, and the
gous mutations on these cotransporters is variable. AtENaC in the collecting duct by amiloride, triamterene,
one extreme, we find no clinical or metabolic manifesta-trimethoprim, or pentamidine?
tions in patients having mutations that result in little orDr. Gamba: Little is known about the structure-func-
mild effect on the function of the cotransporters. At thetion relationship of the electroneutral cotransporters BSC
other extreme, in patients with mutations that do affectand TSC; a little bit more information is available about
the cotransporter functional properties, we find a mildENaC. From the mid-1990s, several studies using radio-
syndrome that could include compensated hypotension,active diuretics such as [3H]bumetanide and [3H]metola-
with or without an exaggerated response to diuretic treat-zone showed that the higher the extracellular Cl2 con-
ment. In addition, another possible consequence of het-centration, the lower the tracer binding to membranes
erozygous mutations is alteration of calcium metabolism.from outer medulla or renal cortex. These studies sug-
Mutations reducing the function of TSC could result ingested that the diuretics compete with Cl2 for the same
increased calcium reabsorption in the DCT and thusbinding site in the cotransporter protein. More recent
in osteoporosis protection, whereas mutations affectingstudies on BSC2 (the basolateral Na1:K1:2Cl2) have
BSC function would reduce calcium reabsorption in theshown, however, that interchanging the first two mem-
TAL and probably increase the risk for osteoporosis.brane-spanning domains between the human and the
Dr. Correa-Rotter: Following this last possibility, itshark isoforms alters the Na1, K1 and bumetanide bind-
has been shown that thiazide diuretics protect againsting kinetics without affecting Cl2 kinetics [16]. These
osteoporosis. The effect of thiazides on calcium reab-findings argue against the hypothesis that Cl2 and bumet-
sorption on DCT could be the major mechanism for thisanide compete for the same site in the protein. However,
protection. However, other possible effects of thiazides,the binding site for loop diuretics on BSC or thiazide-
for example at the bone level, have been proposed.type diuretics on TSC has not been totally defined. More
is known regarding the amiloride-binding site. It is Could you discuss the expression of TSC in tissues other
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than the kidney, or the potential mechanisms for TSC approach, as Dr. Gamba said, the risk of cerebral lesions
should be considerably diminished.effects on those tissues?
Dr. Alfredo Chew-Wong (Department of Nephrol-Dr. Gamba: The expression of a thiazide-sensitive co-
ogy, Instituto Nacional de la Nutricio´n Salvador Zubi-transporter outside the kidney has been suspected for
ra´n): What is the effect of aldosterone and vasopressinmany years, especially in vascular smooth muscle cells
on TSC and ENaC function and expression?[109], because it has been postulated that natriuretic
Dr. Gamba: Aldosterone increases the function ofeffects of thiazides are not sufficient to explain their
both TSC [115] and ENaC [83]. At the molecular level,antihypertensive actions. In fact, thiazide-induced vaso-
Kim et al have shown, using Western blot analysis, thatdilation has been observed [110]. In physiologic studies,
mineralocorticoid administration (fludrocortisone andthe presence of TSC has been proposed in non-renal
aldosterone) increase the amount of TSC protein in renaltissues such as myocardial cells [111], gallbladder epithe-
cortex [108] and that vasopressin increases BSC proteinlial cells [112], and bone cells [113]. In addition, we have
levels in renal medulla [116]. We do not know whethershown that in the winter flounder TSC transcripts are
these increases are due to an increase in mRNA expres-present in several tissues [35]. In mammals, however,
sion; Northern blots were not reported. The effect ofNorthern blot analysis reveals that all tissues are negative
aldosterone on ENaC seems to be more complex becausefor TSC hybridization [8]. Barry et al showed evidence
aldosterone increases the number of functional channelsof thiazide action on bone cells, together with amplifica-
in the plasma membrane [84], but does not affect thetion of TSC sequences by RT-PCR [114]. Unfortunately,
ENaC subunit mRNA levels [117]; thus its effect mightthe full-length cDNA was not cloned, and thus we do
be by promoting redistribution of channels. In regard tonot know exactly the molecular nature of TSC expression
vasopressin, since it has been demonstrated that ENaCin bone cells.
can be phosphorylated by G-coupled receptors followingThiazide-diuretics can produce some effects outside
the addition of several hormones, it is likely that thethe DCT, such as hyperglycemia by non-TSC-related
effect of vasopressin on ENaC function is due to phos-inhibition. The effect of thiazides on glucose metabolism
phorylation. A chronic effect of vasopressin on ENaCcan be explained by their effects on intracellular messen-
has not been found.gers. For example, it is well known that thiazides exhibit
Dr. Harrington: Let me follow up on that question.a weak phosphodiesterase inhibitory property that in
How do you account for the discrepancy between theturn results in cGMP accumulation.
positive effect of vasopressin on sodium reabsorptionDr. Guillermo Garcia Garcia (Hospital Civil de
via cAMP generation in the thick ascending limb and
Guadalajara, Guadalajara, Jalisco, Mexico): Related to
collecting duct, and the fact that hyponatremic patients
the clinical case you presented, what are the current
with the syndrome of inappropriate ADH secretion
recommendations for the treatment of severe hypona- (SIADH) are in zero sodium balance?
tremia? Dr. Gamba: I think that in patients with SIADH, the
Dr. Gamba: We prefer to treat hyponatremia as slowly water-reabsorptive effect of vasopressin is much more
as possible to prevent the development of neurologic important than the sodium-retaining effect. The latter
lesions. In most cases, we use only water restriction and effect occurs mainly in the TAL, thus maintaining medul-
oral sodium supplementation. Only in patients who have lary hypertonicity, which allows intense water reabsorp-
severe and acute hyponatremia, usually hospital-acquired, tion in the collecting duct. In addition, the increased
with severe neurologic manifestations do we use a slow sodium reabsorption in the TAL can be compensated
intravenous sodium replacement. later in the collecting duct by other mechanisms, for
Dr. Harrington: I want to add our experience on this example, by the increased concentration of atrial natri-
question. Our approach is based on the data provided uretic peptide that inhibits sodium reabsorption in the
by Richard Sterns. He distinguished between chronic inner medullary collecting duct. In contrast, vasopressin-
and acute hyponatremia depending on whether hypona- induced water reabsorption occurs along the collecting
tremia developed prior to or after admission to the hospi- duct with no more nephron ahead to provide compensa-
tal; the former patient has chronic and the latter has tion.
acute hyponatremia. Patients with chronic euvolemic hy- Dr. Madias: In relation to the switching of the trans-
ponatremia should be treated conservatively with simple port mode in the thick ascending limb from Na1:Cl2 to
water restriction. Only if vomiting precludes conserva- Na1:K1:2Cl2 cotransport, I have the following questions.
tive treatment do we resort to slow intravenous NaCl Is the switching a consequence of hypertonicity or of
administration. The serum sodium concentration should vasopressin itself? Can the two cotransporter modes co-
be raised by no more than 0.5 mEq/liter/hour over the exist, or they are on and off mechanisms? Finally, what
first 24 hours with the goal of reaching a serum sodium lessons have we learned from Brattleboro rats?
Dr. Gamba: The switching from Na1:Cl2 tolevel of no more than 120 to 125 mEq/liter. With this
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Na1:K1:2Cl2 cotransporter in TAL is due to both vaso- reabsorption is increased and edema develops. What
do we know about changes in the expression of thesepressin and hypertonicity. In the absence of vasopressin
and during isotonicity or hypotonicity, most of the Na1 cotransporters in pathologic conditions?
Dr. Gamba: We know very little because few studiestransport is K1 independent, that is, due to the Na1:Cl2
cotransport. In the presence of vasopressin or hyperto- have been conducted on this subject. BSC1 expression
has been studied in two different syndromes. Accordingnicity, all the Na1 is transported through a K1-dependent
mechanism, that is, the Na1:K1:2Cl2 cotransporter [5, 6]. to Marumo et al, BSC1 expression at the mRNA level
increases during chronic heart failure [119]. In theirWe do not know whether these two cotransporters can
coexist; dose-dependence studies on vasopressin and in- study, the increase was small but significant. In contrast,
BSC1 is downregulated in nephrotic syndrome, as a po-terstitial tonicity have not been performed. It is possible
that with a mild concentration of vasopressin or a mild tential mechanism of losing the concentrating ability dur-
ing this syndrome [23]. Thiazide-sensitive cotransporterincrease in tonicity, the two cotransporters can coexist
in the same tubule. We have no information from the expression has not been assessed under any pathologic
condition and, to my knowledge, BSC1 expression hasBrattleboro rats because switching of furosemide-sensi-
tive cotransporters has never been assessed in this model. not been studied in other edematous states such as
chronic liver failure.Dr. Luis Gonza´lez-Michaca (Department of Ne-
phrology, Instituto Nacional de la Nutricio´n Salvador Dr. Chevaile: Has anyone looked systematically for
potential mutations in BSC, TSC, or ENaC in a moreZubira´n): You said that patients with Liddle’s syndrome
exhibit mutations in ENaC b or g subunits, but not in common cause of hypertension, like essential hyperten-
sion?the a subunit. What could happen in the hypothetical
case of mutations in the a subunit? Dr. Gamba: It is possible that this is currently being
done. However, no studies of linkage analysis of theseDr. Gamba: Mutations in the carboxy-terminal do-
main of ENaC b or g subunits, by truncation of the genes in hypertension have been reported.
Dr. Pilar Fonseca (Assistant Professor, Universidadprotein or single point mutations, result in disruption of
a particular sequence known as the PY motif. The ab- Auto´noma de San Luis Potosı´): Has a furosemide-sensi-
tive cotransporter been characterized in the brain? Whatsence of the PY motif prevents the interaction of ENaC
with Nedd4 and reduces the possibility of ENaC to be would be its function?
Dr. Gamba: The BSC2 isoform, which is ubiquitouslyubiquitinated and degraded. Therefore, the ENaC half-
life is increased. No mutations have been detected in expressed in the body, is also expressed in the central
nervous system. It has two functions in this organ: itthe ENaC a subunit in Liddle’s syndrome. However,
according to Staub et al [99], the three ENaC subunits serves as a protein involved in cell volume regulation
and it regulates GABA cotransporters by changing intra-interact with Nedd4. Since truncation of a single subunit,
either b or d, affects ENaC-Nedd4 interactions, then cellular chloride concentration.
Dr. Madias: Could you comment on the functionalhypothetically truncation in the carboxy-terminal do-
main of the a subunit also could decrease the ENaC- interactions between the extracellular Ca21-sensing re-
ceptor in the TAL and the various transport systems inNedd4 interaction and result in Liddle’s syndrome.
Dr. Madias: Is it known whether patients with PHA-1 this nephron segment?
Dr. Gamba: Calcium inhibits salt reabsorption in theor Liddle’s syndrome exhibit evidence of altered expres-
sion of the ENaC in organs other than the kidney? TAL, and this effect seems to be mediated by the extra-
cellular Ca21-sensing receptor. This receptor is heavilyDr. Gamba: The clinical picture for both Liddle’s syn-
drome and PHA-1 is mainly due to the renal conse- expressed in the basolateral membrane of the TAL. The
higher the extracellular Ca21, the higher the intracellularquences of the mutations. Liddle’s syndrome is charac-
terized by early and severe hypertension with low plasma production of arachidonic acid derivatives, such as 20-
HETE, and the greater the degree of PLA2 activation.renin activity, metabolic alkalosis, hypokalemia, and low
urinary aldosterone excretion. On the other hand, These compounds inhibit the Na1:K1:2Cl2 cotrans-
porter, inhibit ROMK (the apical ATP-sensitive K1PHA-1 results in a severe salt-wasting syndrome charac-
terized by dehydration, hyperkalemia, hyponatremia, channels), and block vasopressin-induced cAMP genera-
tion, thus reducing salt reabsorption in the TAL.and metabolic acidosis. But two forms of PHA exist,
one that is autosomal-dominant that is mild and mainly
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involves the kidney, and the autosomal-recessive form Salvador Zubira´n, Vasco de Quiroga No. 15, Tlalpan 14,000 Me´xico
D.F.that is more severe and affects several organs [118].
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